⌘K

Login Start Free

Home/Insiders/Aggarwal Sumit

AS

SEC Insider//CIK 0001854362

Aggarwal Sumit

CIK 00018543621 companyARLINGTON, MA

Transactions

12

Companies

1

Filings

7

CIK

0001854362

Recent Transactions

12 trades

Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2025-01-24−30,000→ 30,000 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2025-01-24+30,000→ 199,930 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock
2024-10-16+165,000→ 169,930 total
Award
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2024-01-24+60,000→ 60,000 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2023-01-25+68,700→ 68,700 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2021-12-01+279,158→ 279,158 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2021-12-01−279,158→ 0 total
Tax Payment
Eloxx Pharmaceuticals, Inc.
Common Stock
2021-12-01$0.72/sh−81,933→ 197,225 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2021-05-18+992,409→ 992,409 total
Award
Eloxx Pharmaceuticals, Inc.
Stock Options (Right to Buy)
2021-04-01+1,423,238→ 1,423,238 total
Award
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2021-04-01+223,304→ 223,304 total
Award
Eloxx Pharmaceuticals, Inc.
Restricted Stock Units
2021-04-01+55,854→ 279,158 total

Companies

1

Eloxx Pharmaceuticals, Inc.
Director

Recent Filings

7

Address

C/O ELOXX PHARMACEUTICALS, INC. P.O. BOX 274

ARLINGTON, MA, 02476

View on SEC.gov